ATLANTA & COPENHAGEN, Denmark--(BUSINESS WIRE)--CP Kelco U.S., Inc., (“CP Kelco”) a unit of J.M. Huber Corporation, and Fluxome Sciences A/S, a Copenhagen-based Danish biotechnology company, announced today that they have entered into an agreement to jointly develop and commercialize fermentation derived resveratrol for the dietary supplement, food, beverage, and cosmetics markets. Resveratrol, a potent antioxidant normally found in grapes and red wine, has been associated with positive effects on aging, cardiovascular health, diabetes, obesity and certain cancers. Resveratrol is believed to be a contributing factor to the “French Paradox.” This refers to the fact that despite a diet that is rich in saturated fats, the French population has a relatively low incidence of coronary heart disease.
